Munk Dialogue with Paul Offit
Munk Dialogue with Paul Offit
The Bivalent COVID-19 Booster: do the benefits outweigh the risks?
Health Canada, the FDA, and the CDC have approved COVID bivalent vaccines to anyone over the age of 12. This booster is different from previous COVID shots, targeting multiple strains of the novel coronavirus, including Omicron sub variants. And while the vaccine is being widely distributed, some epidemiologists are sounding the alarm.
Dr. Paul Offit, Director of the Vaccine Education Center and attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia, is one of two members on the FDA committee who voted against advising all adults over the age of 12 to get the jab. Offit joins Rudyard Griffiths for a talk about the Bivalent COVID-19 boosters, who should be getting them, and where more study is warranted.
“The data that we were shown didn’t make it clear that the bivalent vaccine was any better…boosters are a value, but I don’t see why the bivalent one is better than what we have already been getting.”
– PAUL OFFIT
You may also like
April 30, 2024
– Listen
Israel vs. Iran Debate
May 6, 2024
– Listen
Munk Dialogue with Charles Asher Small
May 14, 2024
– Listen
Campus Protests Debate
May 21, 2024
– Listen
Elites Debate
May 28, 2024
– Listen
Gaza Genocide Debate
June 4, 2024
– Listen
Munk Dialogue with David Sanger
June 11, 2024
– Listen
Munk Dialogue with Douglas Murray, Natasha Hausdorff, Mehdi Hasan & Gideon Levy
June 18, 2024
– Listen
Munk Dialogue with David Ignatius
June 25, 2024
– Listen
Anti-Zionism Debate
July 5, 2024
– Listen
Munk Dialogue with John Mackey
July 9, 2024
– Listen
Biden Debate
July 18, 2024